Comparatives Analysis of Inflammatory and Biochemical Markers in Dialysis Patients: The Impact of Age and Sex
Main Article Content
Abstract
Dialysis is a medical procedure that replaces the kidneys when they are unable to function normally. It helps to keep the blood's chemical balance safe by eliminating waste, extra fluid, and toxins. Haemodialysis and peritoneal dialysis are the two primary varieties. A total of 50 patients were enrolled between August and December 2024. Blood samples were collected to assess kidney function through blood urea, serum creatinine, glucose, and estimated glomerular filtration rate (GFR). Inflammatory biomarkers Monocyte Chemoattractant Protein-1 (MCP-1) and E-selectin were measured using ELISA. Blood pressure readings were also recorded. The results revealed that Analyzes compared differences based on sex and across age groups (16–32, 33–48, 49–64, and 65–80 years) using one‐sample t‐tests, independent samples t‐tests, and one‐way ANOVAs.
Significant differences were observed particularly in MCP-1 between females and males, while analyzes of age groups revealed modest trends with low variance explained. These findings support the need for personalized monitoring strategies that consider sex as a key factor in the management of dialysis patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Kimmel, P. L., & Weiner, D. E. (2020). End-stage renal disease and the progression of kidney failure. Journal of Nephrology, 33(1), 45-57. https://doi.org/10.1007/s40620-020-00750-2
Vaziri, N. D. (2021). Role of oxidative stress and inflammation in cardiovascular disease associated with uremia. Seminars in Dialysis, 34(3), 124-130. https://doi.org/10.1111/sdi.13011
Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., ... & Stenvinkel, P. (2021). Aspects of immune dysfunction in end-stage renal disease. Nature Reviews
Kooman, J. P., et al. (2012). Uremic toxins, inflammation, and cardiovascular disease in dialysis patients. Seminars in Dialysis, 25(2), 147-153.
Soehendra, N., et al. (2021). E-selectin and its role in chronic inflammation in dialysis patients. Journal of Vascular Research, 58(4), 211-217.
Uchida, S., et al. (2022). Influence of diabetes, hypertension, and vascular disease on E-selectin levels in end-stage renal disease patients. American Journal of Kidney Diseases, 79(4), 525-533.
Pecoits‐Filho, R., et al. (2020). Aging, sex differences, and inflammation in dialysis patients: A comprehensive review. Nephrology Dialysis Transplantation, 35(1), 69-77.
Matsumoto, T., et al. (2020). Gender differences in inflammatory markers and their association with cardiovascular events in peritoneal dialysis patients. Peritoneal Dialysis International, 40(4), 350-358.
Vaziri, N. D., & Rodby, R. A. (2019). Immunological aspects of end-stage renal disease: The effects of age and gender on inflammatory markers. Nephrology Dialysis Transplantation, 34(2), 233-241.
Carrero, JJ, et al. (2018). Sex differences in inflammatory markers and potential associated cardiovascular outcomes in dialysis patients. Nephrology Dialysis Transplantation, 25(2), 429–435. https://doi.org/10.1093/ndt/gfp915
Kooman, JP, et al. (2009). Inflammation and uremia: etiology and clinical implications. International Urology and Nephrology, 41(2), 319–326. https://doi.org/10.1007/s11255-008-9426-9
Liangos, O., et al. (2006). Aging and the immune response in patients with kidney disease. Journal of the American Society of Nephrology, 17(10), 2952–2958. https://doi.org/10.1681/ASN.2006010012
Stenvinkel, P., et al. (2005). Inflammation in end-stage renal disease: The hidden enemy. Nephrology Dialysis Transplantation, 20(3), 566–569. https://doi.org/10.1093/ndt/gfh046
Li, PK, Chow, KM, & Szeto, CC (2020). The clinical epidemiology of peritoneal dialysis: an update. Nature Reviews Nephrology, 16(3), 158-172.
Betjes, MGH (2020). Immune cell dysfunction and inflammation in end-stage renal disease. Nature Reviews Nephrology, 16(7), 407-418. https://doi.org/10.1038/s41581-020-0291-5.
IBM Corp. (2023). IBM SPSS Statistics for Windows, Version 2023. IBM Corp.